Patients & Caregivers
Considering a Prostate Biopsy
Diagnosing Prostate Cancer
Making the Right Treatment Decision
Our Lab Services
PCA3: Strong Clinical Validation
: Confirm negative biopsies with CONFIDENCE
Accurately classify a “true negative” patient with a high negative predictive value of 90%.
Men with a PCA3 Score of <25 are 4.58 times less likely to have a positive result on repeat biopsy than men with a score of 25 or greater.
Large, independent NCI study confirms 90% NPV for men with low PCA3 score
Gittleman, Marc C, et al. PCA3
Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study
The Journal of Urology, Vol. 190, (2013): 64-69.
Wei, et al. Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
Journal of Clinical Oncology
. 11/2014; 32(36).
PCA3 assay is provided to Metamark by Hologic.
Sample Collection and Preparation
The PCA3 Report
How to Order